JAMES VANDERMARK: Open Payments
NPI 1609534791 · SCHERERVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 28 payments from 10 companies in 2025. Trend: 2023 $1,638 · 2024 $1,277 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $242 |
| VERTEX PHARMACEUTICALS INCORPORATED | 6 | $110 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Indivior Inc. | 1 | $25 |
| Stryker Corporation | 1 | $22 |
| SCILEX PHARMACEUTICALS INC. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| IBSA Pharma Inc. | 1 | $14 |
Products named: QULIPTA, JOURNAVX, UBRELVY, RELISTOR, NURTEC ODT, SUBLOCADE, LINZESS, AUGMENT INJECTABLE.
Industry payments across IN — which companies pay providers there.
